Showing results (691-700 of 45,158) with videos related to
Sort By:
Pageof 4,516
Cancer Research|July 4, 2003
P53 physically interacts with mitochondrial transcription factor A and differentially regulates binding to damaged DNAYoichiro Yoshida, Hiroto Izumi, Takayuki Torigoe, et al.Cancer Research|July 4, 2003
SU5416 and SU6668 attenuate the angiogenic effects of radiation-induced tumor cell growth factor production and amplify the direct anti-endothelial action of radiation in vitroAmir Abdollahi, Kenneth E Lipson, Xiaohong Han, et al.Cancer Research|July 4, 2003
Regulation of multiple tumor microenvironment markers by overexpression of single or paired combinations of ErbB receptorsMoulay A Alaoui-Jamali, Daniel J Song, Naciba Benlimame, et al.Cancer Research|July 4, 2003
Down-regulation of activin, activin receptors, and Smads in high-grade breast cancerJacqueline S Jeruss, Charles D Sturgis, Alfred W Rademaker, et al.Cancer Research|July 4, 2003
3'-deoxy-3'-[18F]fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomographyHenryk Barthel, Marcel C Cleij, David R Collingridge, et al.Cancer Research|July 4, 2003
RNA interference-mediated silencing of the fatty acid synthase gene attenuates growth and induces morphological changes and apoptosis of LNCaP prostate cancer cellsEllen De Schrijver, Koen Brusselmans, Walter Heyns, et al.Cancer Research|July 4, 2003
Photodynamic therapy mediates immediate loss of cellular responsiveness to cytokines and growth factorsTak-Wah Wong, Erin Tracy, Allan R Oseroff, et al.Cancer Research|July 4, 2003
The synthetic heteroarotinoid SHetA2 induces apoptosis in squamous carcinoma cells through a receptor-independent and mitochondria-dependent pathwayKyung-Hee Chun, Doris M Benbrook, K Darrell Berlin, et al.Cancer Research|June 18, 2003
Persistent oxidative stress in chromosomally unstable cellsCharles L Limoli, Erich Giedzinski, William F Morgan, et al.Cancer Research|June 18, 2003
Interleukin-6 fused to an anti-idiotype antibody in a vaccine increases the specific humoral immune response against CA125+ (MUC-16) ovarian cancerSilke Reinartz, Andreas Hombach, Siegmund Köhler, et al.Pageof 4,516